ISSN 2415-1297 (Online)   ISSN 2415-1300 (Print)
 
             
 
Volume : 30 Issue : 1 Year : 2023
 
Clinical Significance of Anticardiolipin Antibodies in Systemic Lupus Erythematosus [Med J Islamic World Acad Sci]
Med J Islamic World Acad Sci. 1989; 2(3): 189-192

Clinical Significance of Anticardiolipin Antibodies in Systemic Lupus Erythematosus

Sibel Ergüven1, Meral Calgüner2, A. Metin Gülmezoğlu3, Ekrem Gülmezoğlu1, Cem Sungur2, Osman Özcebe2
1From Hacettepe University, Department of Microbiology, Ankara, Turkiye.
2From Hacettepe University, Department of Internal Medicine, Ankara, Turkiye.
3From Dr. Zekai Tahir Burak Women’s Hospital, Ankara,Türkiye.

We studied anticardiolipin antibody isotypes and VDRL in 45 systemic lupus erythematosus (SLE) patients. These patients were also screened for some other autoantibodies, such as anti-DNA, antimitochondrial (AMA) type 5 and antinuclear antibodies. Out of 45 patients, 55.5% were anticardiolipin (ACL) antibody positive. IgG class ACL antibodies were mainly detected in patients having thrombotic events and fetal losses. IgM class ACL antibody positivity was only associated with fetal losses. We also found a significant correlation between the presence of AMA type 5 and VDRL positivity with ACL-IgG and ACL-IgM antibodies.

Keywords: Anticardiolipin antibodies, fetal loss, antinuclear antibodies.


Sibel Ergüven, Meral Calgüner, A. Metin Gülmezoğlu, Ekrem Gülmezoğlu, Cem Sungur, Osman Özcebe. Clinical Significance of Anticardiolipin Antibodies in Systemic Lupus Erythematosus. Med J Islamic World Acad Sci. 1989; 2(3): 189-192

Corresponding Author: Sibel Ergüven, Türkiye


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar




   
Copyright © 2024 medicaljournal-ias.org. All Rights Reserved.